Xponance Inc. Acquires 8,312 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Xponance Inc. raised its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 67.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,686 shares of the company’s stock after acquiring an additional 8,312 shares during the quarter. Xponance Inc.’s holdings in Ryan Specialty were worth $1,198,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in RYAN. Champlain Investment Partners LLC lifted its position in Ryan Specialty by 28.0% during the first quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company’s stock valued at $274,022,000 after acquiring an additional 1,079,505 shares during the last quarter. Norden Group LLC lifted its holdings in shares of Ryan Specialty by 2,138.1% during the 1st quarter. Norden Group LLC now owns 778,848 shares of the company’s stock valued at $43,226,000 after purchasing an additional 744,049 shares during the last quarter. Bessemer Group Inc. boosted its position in shares of Ryan Specialty by 33.9% in the 1st quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company’s stock worth $106,886,000 after purchasing an additional 488,067 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Ryan Specialty by 132.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company’s stock worth $48,425,000 after purchasing an additional 476,126 shares in the last quarter. Finally, Norges Bank purchased a new position in Ryan Specialty during the 4th quarter worth $16,964,000. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Ryan Specialty news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the company’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $65.18, for a total value of $1,709,866.94. Following the completion of the transaction, the executive vice president now owns 24,845 shares in the company, valued at $1,619,397.10. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, Director Nicholas Dominic Cortezi sold 5,375 shares of Ryan Specialty stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total value of $347,923.75. Following the sale, the director now owns 2,685 shares of the company’s stock, valued at approximately $173,800.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the business’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the completion of the sale, the executive vice president now directly owns 24,845 shares of the company’s stock, valued at approximately $1,619,397.10. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,107,136 shares of company stock valued at $131,860,032. Corporate insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. The Goldman Sachs Group raised their price target on Ryan Specialty from $58.00 to $64.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $65.00 to $75.00 in a research report on Tuesday. Barclays initiated coverage on shares of Ryan Specialty in a research note on Wednesday, September 4th. They set an “overweight” rating and a $76.00 price target on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday, August 2nd. Finally, Wells Fargo & Company boosted their price objective on shares of Ryan Specialty from $60.00 to $63.00 and gave the company an “equal weight” rating in a report on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $66.78.

Get Our Latest Stock Report on RYAN

Ryan Specialty Trading Down 0.3 %

Shares of Ryan Specialty stock opened at $66.00 on Friday. Ryan Specialty Holdings, Inc. has a 1 year low of $41.49 and a 1 year high of $69.03. The company has a debt-to-equity ratio of 1.81, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market cap of $17.26 billion, a PE ratio of 124.53, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The firm has a fifty day moving average price of $63.85 and a 200 day moving average price of $57.64.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.02. The business had revenue of $695.40 million during the quarter, compared to analysts’ expectations of $695.56 million. Ryan Specialty had a return on equity of 48.08% and a net margin of 10.21%. The company’s revenue for the quarter was up 18.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.45 EPS. Equities research analysts predict that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Tuesday, August 13th were paid a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 13th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.67%. Ryan Specialty’s payout ratio is 83.02%.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.